Literature DB >> 18537568

Current in vitro kinase assay technologies: the quest for a universal format.

Yong Jia1, Christopher M Quinn, Silvia Kwak, Robert V Talanian.   

Abstract

The rapidly growing interest in kinases as drug targets has prompted the development of many kinase assay technologies. These technologies can be grouped into three categories: radiometric assays, phospho-antibody-dependent fluorescence/luminescence assays, and phospho-antibody-independent fluorescence/luminescence assays. This article will review some of the major kinase assay technologies on the market, with particular emphasis on the newest systems. We will describe the physical principles, the practical advantages and drawbacks, and the potential applications of these technologies in kinase drug discovery. Most of these technologies are suitable for HTS, but only a few can be utilized for kinetic and mechanistic studies. Significant progress towards development of generic assays, free of radioisotopes and custom reagents such as phospho-specific antibodies, has been made in recent years. However, due to various limitations of each format, none of these generic assay technologies can yet claim to be truly universal. Several factors, including the intended applications, cost, timeline, expertise, familiarity, and comfort level, should be considered prior to pursuing a particular kinase assay technology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18537568     DOI: 10.2174/157016308783769414

Source DB:  PubMed          Journal:  Curr Drug Discov Technol        ISSN: 1570-1638


  21 in total

1.  Photocleavable peptide-oligonucleotide conjugates for protein kinase assays by MALDI-TOF MS.

Authors:  Guangchang Zhou; Faraz Khan; Qing Dai; Juliesta E Sylvester; Stephen J Kron
Journal:  Mol Biosyst       Date:  2012-07-06

2.  Identification of novel CK2 inhibitors with a benzofuran scaffold by novel non-radiometric in vitro assays.

Authors:  Andreas Gratz; Uwe Kuckländer; Ricardo Bollig; Claudia Götz; Joachim Jose
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

Review 3.  Impact of high-throughput screening in biomedical research.

Authors:  Ricardo Macarron; Martyn N Banks; Dejan Bojanic; David J Burns; Dragan A Cirovic; Tina Garyantes; Darren V S Green; Robert P Hertzberg; William P Janzen; Jeff W Paslay; Ulrich Schopfer; G Sitta Sittampalam
Journal:  Nat Rev Drug Discov       Date:  2011-03       Impact factor: 84.694

4.  Integrated microfluidic and imaging platform for a kinase activity radioassay to analyze minute patient cancer samples.

Authors:  Cong Fang; Yanju Wang; Nam T Vu; Wei-Yu Lin; Yao-Te Hsieh; Liudmilla Rubbi; Michael E Phelps; Markus Müschen; Yong-Mi Kim; Arion F Chatziioannou; Hsian-Rong Tseng; Thomas G Graeber
Journal:  Cancer Res       Date:  2010-09-13       Impact factor: 12.701

5.  Studies on quantitative phosphopeptide analysis by matrix-assisted laser desorption/ionization mass spectrometry without label, chromatography or calibration curves.

Authors:  Hsin-Pin Ho; Pratikkumar Rathod; Marissa Louis; Christine K Tada; Sherida Rahaman; Kevin J Mark; Jin Leng; Dibyendu Dana; Sanjai Kumar; Mathias Lichterfeld; Emmanuel J Chang
Journal:  Rapid Commun Mass Spectrom       Date:  2014-12-30       Impact factor: 2.419

6.  Fluorescence polarization assays in small molecule screening.

Authors:  Wendy A Lea; Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2011-01       Impact factor: 6.098

7.  Development of a sensitive non-radioactive protein kinase assay and its application for detecting DYRK activity in Xenopus laevis oocytes.

Authors:  Eva Lilienthal; Katharina Kolanowski; Walter Becker
Journal:  BMC Biochem       Date:  2010-05-20       Impact factor: 4.059

8.  Monitoring ATP hydrolysis and ATPase inhibitor screening using (1)H NMR.

Authors:  Bingqian Guo; Pinar S Gurel; Rui Shu; Henry N Higgs; Maria Pellegrini; Dale F Mierke
Journal:  Chem Commun (Camb)       Date:  2014-10-18       Impact factor: 6.222

Review 9.  Matching the power of high throughput screening to the chemical diversity of natural products.

Authors:  Curtis J Henrich; John A Beutler
Journal:  Nat Prod Rep       Date:  2013-08-08       Impact factor: 13.423

10.  Rational Design of a Dephosphorylation-Resistant Reporter Enables Single-Cell Measurement of Tyrosine Kinase Activity.

Authors:  Abigail H Turner; Michael S Lebhar; Angela Proctor; Qunzhao Wang; David S Lawrence; Nancy L Allbritton
Journal:  ACS Chem Biol       Date:  2015-12-04       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.